These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Evidence for a Mesothelial Origin of Body Cavity Effusion Lymphomas. Sanchez-Martin D; Uldrick TS; Kwak H; Ohnuki H; Polizzotto MN; Annunziata CM; Raffeld M; Wyvill KM; Aleman K; Wang V; Marshall VA; Whitby D; Yarchoan R; Tosato G J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28376153 [TBL] [Abstract][Full Text] [Related]
5. Kaposi sarcoma-associated herpesvirus (human herpesvirus type 8)-associated extracavitary lymphoma: Report of a case in an HIV-positive patient with simultaneous kaposi sarcoma and a review of the literature. Zhang H; Yang XY; Hong T; Feldman T; Bhattacharyya PK Acta Haematol; 2010; 123(4):237-41. PubMed ID: 20484888 [TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus. Bigi R; Landis JT; An H; Caro-Vegas C; Raab-Traub N; Dittmer DP Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11379-E11387. PubMed ID: 30429324 [TBL] [Abstract][Full Text] [Related]
7. X-box binding protein 1 induces the expression of the lytic cycle transactivator of Kaposi's sarcoma-associated herpesvirus but not Epstein-Barr virus in co-infected primary effusion lymphoma. Lai IY; Farrell PJ; Kellam P J Gen Virol; 2011 Feb; 92(Pt 2):421-31. PubMed ID: 20980528 [TBL] [Abstract][Full Text] [Related]
8. Virological and molecular characterisation of a new B lymphoid cell line, established from an AIDS patient with primary effusion lymphoma, harbouring both KSHV/HHV8 and EBV viruses. Lacoste V; Judde JG; Bestett G; Cadranel J; Antoine M; Valensi F; Delabesse E; Macintyre E; Gessain A Leuk Lymphoma; 2000 Jul; 38(3-4):401-9. PubMed ID: 10830748 [TBL] [Abstract][Full Text] [Related]
9. Elevated IL-13 in effusions of patients with HIV and primary effusion lymphoma as compared with other Kaposi sarcoma herpesvirus-associated disorders. Ramaswami R; Lurain K; Marshall VA; Rupert A; Labo N; Cornejo-Castro E; Miley W; Wang HW; Widell A; Lindsley M; Yuan C; Stetler-Stevenson M; Filie AC; Whitby D; Ziegelbauer JM; Uldrick TS; Yarchoan R AIDS; 2021 Jan; 35(1):53-62. PubMed ID: 33273183 [TBL] [Abstract][Full Text] [Related]
10. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression. Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248 [TBL] [Abstract][Full Text] [Related]
11. Viral, immunologic, and clinical features of primary effusion lymphoma. Lurain K; Polizzotto MN; Aleman K; Bhutani M; Wyvill KM; Gonçalves PH; Ramaswami R; Marshall VA; Miley W; Steinberg SM; Little RF; Wilson W; Filie AC; Pittaluga S; Jaffe ES; Whitby D; Yarchoan R; Uldrick TS Blood; 2019 Apr; 133(16):1753-1761. PubMed ID: 30782610 [TBL] [Abstract][Full Text] [Related]
12. Extracavitary KSHV-associated large B-Cell lymphoma: a distinct entity or a subtype of primary effusion lymphoma? Study of 9 cases and review of an additional 43 cases. Pan ZG; Zhang QY; Lu ZB; Quinto T; Rozenvald IB; Liu LT; Wilson D; Reddy V; Huang Q; Wang HY; Ren YS Am J Surg Pathol; 2012 Aug; 36(8):1129-40. PubMed ID: 22790853 [TBL] [Abstract][Full Text] [Related]
13. Kaposi sarcoma herpesvirus/human herpesvirus-8-negative effusion-based lymphoma: report of 3 cases and review of the literature. Xiao J; Selvaggi SM; Leith CP; Fitzgerald SA; Stewart J Cancer Cytopathol; 2013 Nov; 121(11):661-9. PubMed ID: 23765802 [TBL] [Abstract][Full Text] [Related]